Question 1

What specific types of cancer are being studied in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells clinical trial (NCT04628806). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the results of the HSP70 test impact my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells clinical trial (NCT04628806). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or side effects of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells clinical trial (NCT04628806). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for blood tests during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells clinical trial (NCT04628806). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I decide to participate but then want to withdraw?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells clinical trial (NCT04628806). Contact the study team or your healthcare provider for specific answers.

What this study is about